IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Ventricular Arrhythmia, Ventricular Tachycardia, Premature Ventricular Contraction (PVC), Cardiomyopathy. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States, Canada, Israel, Japan, Netherlands +2
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
An International VT Ablation Center Collaborative Group (IVTCC): A Multicenter Ventricular Tachycardia Catheter Ablation Registry
Overview
This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.
Detailed description
Sudden cardiac death (SCD), predominantly due to ventricular tachyarrhythmias, is a leading cause of mortality in the United States and around the world. Catheter ablation of ventricular arrhythmias has proven efficacious in reducing the burden of arrhythmias and reducing implantable cardiac defibrillator (ICD) shocks.
The aim of this study is to create a prospective international database registry that will allow for better assessment of the outcomes of catheter ablation of ventricular arrhythmias. The registry, with approximately 30 participating centers, will help to identify the overall success rates and associated benefits of the procedure and provide more comprehensive data on understudied populations and treatment.
Primary outcome measures
- Ventricular tachycardia (VT) recurrence [Time frame: From date of procedure assessed by shock, Anti-Tachycardia Pacing, or repeat procedure, up to 10 years.]
Secondary outcome measures (2)
- Rate of complications [Time frame: From date of procedure assessed up to 12 months.]
- Time to transplant or death [Time frame: From date of procedure assessed by date of transplant and/or death, up to 10 years.]
Eligibility criteria
Inclusion criteria
\- All patients undergoing catheter ablation for ventricular tachycardia (VT) or premature ventricular contractions (PVCs).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 34 centers
- Banner Health, University of Arizona Medical Center — Phoenix
- Cedars-Sinai Medical Center — Los Angeles
- University of California, Los Angeles — Los Angeles
- University of California, Davis — Sacramento
- University of California San Francisco — San Francisco
- University of Colorado Hospital — Aurora
- Hartford HealthCare — Hartford
- University of Florida Health — Gainesville
- … and 26 more centers
Netherlands · 2 centers
- Leiden University — Leiden
- Erasmus Medical Center — Rotterdam
Canada · 1 center
- The Montreal Heart Institute — Montreal
Israel · 1 center
- Shaare Zedek Medical Center — Jerusalem
Japan · 1 center
- Dokkyo Medical University Koshigaya Hospital — Koshigaya
Spain · 1 center
- Gregorio Marañón General University Hospital — Madrid
United Kingdom · 1 center
- St. George's Hospital — Wandsworth
Identifiers
NCT: NCT04520347 · 17-001725